Change - Announcement of Cessation::Cessation of Chief Financial Officer

Issuer & Securities

Issuer/ Manager
CHINA MEDICAL (INTERNATIONAL) GROUP LIMITED
Securities
CHINA MED (INTL) W201029 - SG5FF2000003 - 1F6W
CHINA MEDICAL (INTL) GROUP LTD - SG1T21929867 - 5IB
Stapled Security
No

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
31-Dec-2018 13:59:55
Status
New
Announcement Sub Title
Cessation of Chief Financial Officer
Announcement Reference
SG181231OTHR02TY
Submitted By (Co./ Ind. Name)
Tan Swee Gek
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)
This announcement has been prepared by the Company and its contents have been reviewed by the Company's sponsor,
PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor") for compliance with the Singapore Exchange Securities Trading Limited (the "SGX-ST") Listing Manual Section B: Rules of Catalist. The Sponsor has not verified the contents of this announcement.

This announcement has not been examined or approved by the SGX-ST. The Sponsor and the SGX-ST assume no responsibility for the contents of this announcement, including the accuracy, completeness or correctness of any of the information, statements or opinions made or reports contained in this announcement.

The contact person for the Sponsor is Ms Gillian Goh, Director, Head of Continuing Sponsorship (Mailing Address: 16 Collyer Quay, #10-00 Income at Raffles, Singapore 049318 and E-mail: sponsorship@ppcf.com.sg).

Additional Details

Name Of Person
Albert Tan Tiong Heng (Chen Zhongxing)
Age
47
Is effective date of cessation known?
Yes
If yes, please provide the date
31/12/2018
Detailed Reason (s) for cessation
To pursue other career opportunities.

Based on its enquiries, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that, other than as
disclosed in the announcement, there are no material reasons for the resignation of Mr Albert Tan Tiong Heng as the Chief Financial Officer of the Company. In addition, there are no concerns with regards to financial reporting that led to the resignation of the Company's Chief Financial Officer and there are no disagreements between the Chief Financial Officer and the Board of Directors of the Company with regards to practices that will have an impact to the Company's financial reporting.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
No
Date of Appointment to current position
31/01/2017
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
2
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
Chief Financial Officer
Role and responsibilities
Responsible for overseeing the Group's financial and management accounting, treasury, taxation and other corporate and regulatory compliance matters.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
No
Shareholding interest in the listed issuer and its subsidiaries?
No
Past (for the last 5 years)
Nil
Present
China iMyth Company Pte. Ltd.
CMIC Hemodialysis Pte. Ltd.
China iMyth (Hong Kong) Limited
CMIC Hemodialysis (Hong Kong) Limited
CMIG Medical Clinics (Hong Kong) Limited
CMIG Medical Services (Hong Kong) Limited
CMIG Ren Feng Med-Biotechnology Limited
CMIG Ren Feng Medical (Nanshan) Limited
CMIG Ren Feng Medical (Futian) Limited
CMIG GY Sales Limited

The above subsidiaries are part of the Group and the Board will take steps to procure the cessation of Mr Albert Tan Tiong Heng's directorships in such subsidiaries when he is no longer an employee of the Group.